July 17, 2024 08:00 AM EDT
Financing

AI drug de­vel­op­ment com­pa­ny gets $80M back­ing from Pfiz­er, Nvidia and Ther­mo Fish­er

Ayisha Sharma

News Reporter

Pfiz­er, Nvidia and Ther­mo Fish­er have pitched in to help a ma­chine learn­ing firm am­pli­fy its AI ap­proach, which could help bio­phar­ma com­pa­nies bet­ter suc­ceed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times